OKYO Pharma reports 'statistical significance' achieved in P

OKYO Pharma reports 'statistical significance' achieved in Phase 2 trial of OK-101 in dry eye disease

OKYO Pharma reports 'statistical significance' achieved in Phase 2 trial of OK-101 in dry eye disease

proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

, Jay Pepose , Raj Patil , Gabriele Cerrone , Okyo Pharma Ltd , Drug Administration , Pepose Vision Institute , Dry Eye , Developing Drugs , Clinical Ophthalmology , Washington University School ,